Education
About Us
Working with TipRanks
Follow Us
Boston Scientific (GB:0HOY)
LSE:0HOY
Total Valuation
Boston Scientific has a market cap or net worth of $113.10B. The enterprise value is $123.47B.
Market Cap$113.10B
Enterprise Value$123.47B
Share Statistics
Boston Scientific has 1,483,885,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,483,885,500
Owned by Insiders0.16%
Owned by Institutions3.18%
Financial Efficiency
Boston Scientific’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.78%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)8.78%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee378.75K
Profits Per Employee54.57K
Employee Count53,000
Asset Turnover0.46
Inventory Turnover2.11
Valuation Ratios
The current PE Ratio of Boston Scientific is 39.4. Boston Scientific’s PEG ratio is 0.88.
PE Ratio39.4
PS Ratio7.03
PB Ratio5.82
Price to Fair Value5.82
Price to FCF38.59
Price to Operating Cash Flow24.93
PEG Ratio0.88
Income Statement
In the last 12 months, Boston Scientific had revenue of 20.07B and earned 2.89B in profits. Earnings per share was 1.96.
Revenue20.07B
Gross Profit13.85B
Operating Income3.97B
Pretax Income3.38B
Net Income2.89B
EBITDA3.73B
Earnings Per Share (EPS)1.96
Cash Flow
In the last 12 months, operating cash flow was 4.53B and capital expenditures -909.00M, giving a free cash flow of 3.63B billion.
Operating Cash Flow4.53B
Free Cash Flow3.63B
Free Cash Flow per Share2.44
Dividends & Yields
Boston Scientific pays an annual dividend of $0.285, resulting in a dividend yield of ―
Dividend Per Share$0.285
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.79
52-Week Price Change-27.42%
50-Day Moving Average87.39
200-Day Moving Average98.09
Relative Strength Index (RSI)36.45
Average Volume (3m)15.00K
Important Dates
Boston Scientific upcoming earnings date is Apr 29, 2026, Before Open (Confirmed).
Last Earnings DateFeb 4, 2026
Next Earnings DateApr 29, 2026
Ex-Dividend Date―
Financial Position
Boston Scientific as a current ratio of 1.62, with Debt / Equity ratio of 51.24%
Current Ratio1.62
Quick Ratio1.08
Debt to Market Cap0.08
Net Debt to EBITDA2.78
Interest Coverage Ratio11.38
Taxes
In the past 12 months, Boston Scientific has paid 493.00M in taxes.
Income Tax493.00M
Effective Tax Rate0.15
Enterprise Valuation
Boston Scientific EV to EBITDA ratio is 40.59, with an EV/FCF ratio of 41.42.
EV to Sales7.55
EV to EBITDA40.59
EV to Free Cash Flow41.42
EV to Operating Cash Flow33.42
Balance Sheet
Boston Scientific has $2.04B in cash and marketable securities with $12.42B in debt, giving a net cash position of -$10.37B billion.
Cash & Marketable Securities$2.04B
Total Debt$12.42B
Net Cash-$10.37B
Net Cash Per Share-$6.99
Tangible Book Value Per Share-$0.56
Margins
Gross margin is 69.01%, with operating margin of 19.78%, and net profit margin of 14.38%.
Gross Margin69.01%
Operating Margin19.78%
Pretax Margin16.86%
Net Profit Margin14.38%
EBITDA Margin18.60%
EBIT Margin18.60%
Analyst Forecast
The average price target for Boston Scientific is $108.38, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$108.38
Price Target Upside42.08% Upside
Analyst ConsensusStrong Buy
Analyst Count22
Revenue Growth Forecast―
EPS Growth Forecast―